The Triple Agonist Power: Understanding “Ret”
Before we dive into the duo, let’s look at the heavy lifter. Ret is a revolutionary triple agonist. While older compounds focused on one or two metabolic pathways, Ret targets three distinct receptors: GLP-1, GIP, and Glucagon.
- GLP-1 & GIP: These handle the “input” side of the equation: optimizing insulin signaling and keeping your appetite in check so you stay in a calorie deficit without the “hanger.”
- Glucagon Receptors: This is the game-changer. By activating glucagon signaling, Ret signals the body to mobilize stored fat from the liver and adipose tissue. It’s like turning on a high-pressure valve for your fat stores.
Enter MOTS-c: The Mitochondrial Engine
If Ret is the valve that releases the fat, MOTS-c is the furnace that burns it.
MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial DNA itself. It acts as a “metabolic messenger,” signaling your cells to switch into high-efficiency mode. When you introduce MOTS-c into your research protocol, you are essentially activating the AMPK pathway: the same pathway triggered by hours of intense endurance exercise.
At Weight Loss Australia (WLA), we often refer to the AMPK peptide as the “guardian of metabolism.” It enhances glucose uptake in the skeletal muscle and increases mitochondrial biogenesis (the creation of new cellular power plants).
